J. Taylor

发表

Survival of myeloma patients following the introduction of thalidomide as a second‐line therapy: a retrospective study at a single New Zealand centre

P. Ganly, B. Hock, J. Pearson, 2013, Internal medicine journal.

Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden

Peter Donnelly, Gil McVean, Paolo Piazza, 2014, Nature Communications.

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups

J Taylor, D. Bentley, E. Campo, 2017, Leukemia.

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia

C. Yau, S. Knight, C. Holmes, 2012, Leukemia.

T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease.

S. Mackinnon, G. Heller, B. Childs, 1998, Blood.

Correction: Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups

D. Bentley, E. Campo, J. Martín-Subero, 2019, Leukemia.

Erratum: Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups

D. Bentley, E. Campo, J. Martín-Subero, 2017, Leukemia.

Response to trans-retinoic acid in an AMLM3 patient resistant to cis-retinoic acid.

C. Costello, N. Mir, D. Samson, 1991, Leukemia research.